Today: 30 April 2026
Browse Category

Stock Market 25 January 2026

GE Aerospace stock price: GE shares head into Monday after earnings drop, analysts reset targets

GE Aerospace stock price: GE shares head into Monday after earnings drop, analysts reset targets

GE Aerospace shares fell 0.4% to $293.87 Friday, capping a 9.6% slide over five sessions despite several banks raising price targets. The company reported Q4 orders up 74% to $27 billion and adjusted earnings of $1.57 per share, with a backlog near $190 billion. Supply shortages continue to limit new engine deliveries and drive up maintenance demand. Investors await Boeing and RTX earnings on Tuesday.
25 January 2026
···
Chevron stock (CVX) set for Monday focus after Venezuela talks; Tengiz outage lingers

Chevron stock (CVX) set for Monday focus after Venezuela talks; Tengiz outage lingers

Chevron shares closed at $166.72, up 0.04%, after reports the U.S. is discussing a plan with Chevron to boost Venezuela’s crude output. Oil prices surged Friday, with Brent closing at $65.88 and WTI at $61.07, amid Middle East tensions. Chevron’s Kazakhstan operations remain halted after a fire, with crude output sharply reduced. Neither Chevron nor the White House commented on the Venezuela talks.
25 January 2026
··
P&G stock price heads into Monday on JPMorgan upgrade as Fed week looms

P&G stock price heads into Monday on JPMorgan upgrade as Fed week looms

JPMorgan, Wells Fargo, and UBS raised price targets for Procter & Gamble after the company reported flat organic sales and core EPS of $1.88. P&G shares closed at $150.15 Friday. The company repurchased $2.3 billion in shares and paid a $1.0568 dividend last quarter. Investors await the Fed’s policy decision Wednesday and U.S. consumer data Tuesday.
25 January 2026
·
Roche stock hovers near a 52-week high as investors brace for Thursday’s results

Roche stock hovers near a 52-week high as investors brace for Thursday’s results

Roche participation shares closed Friday at 348.10 Swiss francs, up 0.06% and near a 52-week high. The company will report full-year 2025 results before the Swiss market opens on Jan. 29, followed by a management webcast. Investors are watching for 2026 guidance and updates on drug launches and diagnostics demand. The Swiss Market Index fell 0.61% Friday.
25 January 2026
···
SK hynix stock: what traders are watching before Jan. 29 earnings

SK hynix stock: what traders are watching before Jan. 29 earnings

SK hynix shares closed up 1.59% at 767,000 won Friday, near their Jan. 8 intraday high. The company, which held a 61% global HBM market share last year, reports fourth-quarter results Jan. 29. Investors are watching for updates on memory pricing and supply as AI demand strains capacity. CEO Sungsoo Ryu said SK hynix will speed up new fab openings amid “tremendous” demand.
25 January 2026
··
Alibaba stock price slips after AI-chip headlines; BABA traders turn to Fed week

Alibaba stock price slips after AI-chip headlines; BABA traders turn to Fed week

Alibaba’s U.S.-listed shares fell 2.2% to $173.23 Friday, while its Hong Kong stock closed up 2.25%. Traders reacted to reports that Chinese tech firms can order Nvidia’s H200 AI chips and to Alibaba Cloud’s new partner incentives. Bloomberg reported Alibaba plans to take its AI chip unit public. Investors await the U.S. Fed’s rate decision on Jan. 28.
25 January 2026
··
Bank of America stock heads into Fed week after Friday slide — what to watch Monday

Bank of America stock heads into Fed week after Friday slide — what to watch Monday

Bank of America shares fell 1.4% to $51.72 Friday, underperforming a flat S&P 500. A new SEC filing showed the bank is offering fixed-rate callable notes maturing in 2038 with a 5.05% coupon. The KBW Nasdaq Regional Banking Index dropped 3% after First Citizens BancShares warned of weaker 2026 net interest income. Investors are watching the Federal Reserve’s policy meeting next week.
25 January 2026
··
AbbVie stock price: India patent setback on Venclexta puts ABBV in focus before Feb. 4 earnings

AbbVie stock price: India patent setback on Venclexta puts ABBV in focus before Feb. 4 earnings

AbbVie shares rose 0.5% to $219.26 Friday, shrugging off India’s rejection of its patent application for the cancer drug venetoclax. The Indian patent office cited lack of novelty and opposition from seven parties. AbbVie will report Q4 and full-year earnings on Feb. 4. Investors remain focused on patent risks and upcoming guidance as the company adjusts after Humira’s decline.
25 January 2026
···
Micron stock hovers near $400 as Intel flags memory cost pressure; Fed decision next

Micron stock hovers near $400 as Intel flags memory cost pressure; Fed decision next

Micron Technology shares closed up 0.5% at $399.65 Friday, trading near $400 as memory prices and supply shortages drove market moves. Intel stock fell after warning of rising component costs, including memory. Micron reported fiscal Q1 revenue of $13.64 billion and guided Q2 to $18.70 billion. Investors are watching high-bandwidth memory demand and upcoming earnings from major tech firms.
25 January 2026
···
Mastercard stock price falls ahead of earnings week as JPMorgan calls consumer “healthy”

Mastercard stock price falls ahead of earnings week as JPMorgan calls consumer “healthy”

Mastercard shares fell 1.52% to $524.74 Friday on heavy trading, closing the week 13% below their August peak. The company reports Q4 and full-year earnings Thursday, as investors await signals on holiday spending and cross-border volume. The Federal Reserve announces its policy decision Tuesday, with Visa and American Express earnings also due this week.
25 January 2026
··
1 … 395 396 397 398 399 … 1,403

Stock Market Today

  • D-Wave Quantum to Host Inaugural Investor Day at NYSE on June 1, 2026
    April 30, 2026, 3:33 PM EDT. D-Wave Quantum Inc. (NYSE: QBTS), a pioneer in dual-platform quantum computing, will hold its first Investor Day at the New York Stock Exchange and online on June 1, 2026. The event, themed "The D-Wave Difference," aims to present the company's technology leadership, product roadmap, and growth strategy. D-Wave specializes in both annealing and gate-model quantum computing systems, offering enterprise-grade solutions onsite and via its Leap quantum cloud service. Over 100 commercial, government, and research organizations currently rely on D-Wave's quantum computing technology. The Investor Day seeks to clarify the evolving quantum computing sector and demonstrate how D-Wave turns innovation into commercial opportunity.

Latest article

Rezolve AI Stock Rises After Revenue Tops All of 2025 in 90 Days

Rezolve AI Stock Rises After Revenue Tops All of 2025 in 90 Days

30 April 2026
Rezolve AI reported $60 million in first-quarter revenue, surpassing its audited 2025 total of $46.8 million, based on unaudited accounts. Shares rose 4.9% after the update. The company reaffirmed its $360 million 2026 revenue target and said it can reach profitability without new equity sales. Commerce.com, which rejected Rezolve’s all-stock takeover offer, adopted a poison pill defense.
Option Care Health Stock Plunges After 2026 Revenue Cut Exposes Chronic-Therapy Drag

Option Care Health Stock Plunges After 2026 Revenue Cut Exposes Chronic-Therapy Drag

30 April 2026
Option Care Health shares fell 28% to $19.44 after the company cut its 2026 revenue forecast and reported first-quarter sales of $1.35 billion, missing estimates. The company now expects 2026 revenue of $5.675–$5.775 billion, down from a prior range of $5.8–$6.0 billion, citing pressure in its chronic inflammatory disease portfolio. Adjusted profit guidance was unchanged.
Stellantis N.V. Stock Slides: Q1 Profit Rebound Leaves One Big Cash-Flow Question

Stellantis N.V. Stock Slides: Q1 Profit Rebound Leaves One Big Cash-Flow Question

30 April 2026
Stellantis reported a first-quarter net profit of €377 million, reversing a €387 million loss a year earlier, aided by a €400 million expected U.S. tariff refund. Industrial free cash flow remained negative at €1.92 billion. Shares fell 6.4% to €6.22 after the results. CEO Antonio Filosa faces pressure ahead of a May 21 investor day to present a stronger turnaround plan.
Go toTop